Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
omega-3 fatty acids + vitamin E
- Development stage
- Unknown
- Lead developer
- Cairo University
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
omega-3 fatty acids + vitamin E (Cairo University) is a combination nutraceutical product being evaluated for the treatment of mastalgia (breast pain) associated with fibrocystic breast changes. The combination consists of 1000 mg of omega-3 fatty acids (containing eicosapentaenoic acid and docosahexaenoic acid) and 400 IU of Vitamin E (alpha-tocopherol). Omega-3 fatty acids exert anti-inflammatory effects by serving as alternative substrates for cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, thereby reducing the synthesis of pro-inflammatory eicosanoids such as prostaglandin E2 (PGE2). Vitamin E acts as a potent lipid-soluble antioxidant, protecting breast tissue from oxidative damage and lipid peroxidation, which are implicated in the pathogenesis of fibrocystic changes. This combination is currently in Phase 4 clinical development at Cairo University to determine its efficacy in reducing breast pain intensity compared to Vitamin E monotherapy.
- Brand names
- Omega-3 PlusOmega3 PlusOmega 3 Plusω-3 plus
- Other names
- n-3 polyunsaturated fatty acids + vitamin Efish oil + alpha-tocopherolomega-3 fatty acids + alpha-tocopherol
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PPARG (Peroxisome proliferator-activated receptor gamma)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on omega-3 fatty acids + vitamin E.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on omega-3 fatty acids + vitamin E.